CELIMAX

Based in South Korea, CELIMAX, operates as a K-beauty skincare brand focused on developing customer-driven skincare products for sensitive skin, barrier care, hydration, acne care, and anti-aging. Based in Seoul, South Korea and founded in 2019, CELIMAX is a skincare brand that emphasizes customer-driven product development. The company raised KRW 120 billion in Pre-IPO funding on September 23, 2026, from investors including Must Ventures, Pine Tree Investment & Management, and Shinhan Securities. The funding will be used to expand its product portfolio, strengthen distribution channels, and support growth ahead of a potential IPO.

CELIMAX specializes in skincare products designed to address diverse skin concerns, focusing on hydration, brightening, and elasticity. Their core offerings include innovative facial masks and treatment pads that utilize active ingredients like tranexamic acid and retinol. The two-step gel mask system enhances skin rejuvenation by combining a serum with a gel mask, catering to both skincare enthusiasts and professionals, primarily in South Korea and expanding to other Asian markets. Revenue generation at CELIMAX occurs through direct-to-consumer sales, structured around individual product purchases and potential bulk sales to retailers.

Customers can buy products directly from their online platform, with promotional pricing strategies implemented during sales events to encourage volume purchases and customer loyalty. The sales structure promotes consistent revenue from individual consumer purchases and positions the brand for potential partnerships with beauty salons and wellness centers. The company plans to expand its product portfolio, strengthen its domestic and international distribution channels, and accelerate global market expansion in preparation for a potential IPO.